Spherix Global Insights (@spherixinsights) 's Twitter Profile
Spherix Global Insights

@spherixinsights

Spherix Global Insights is a leading provider of market research, business intelligence and advisory services to the global life sciences industry.

ID: 4025773487

linkhttp://www.spherixglobalinsights.com/ calendar_today23-10-2015 17:47:03

875 Tweet

326 Takipçi

817 Takip Edilen

Spherix Global Insights (@spherixinsights) 's Twitter Profile Photo

Sanofi announced positive Phase 2 data of their novel second-generation investigational anti-CD40L antibody, frexalimab, significantly reduced disease activity of patients with relapsing MS & met the primary endpoint. Read more hubs.la/Q01R-Zmd0

Sanofi announced positive Phase 2 data of their novel second-generation investigational anti-CD40L antibody, frexalimab, significantly reduced disease activity of patients with relapsing MS & met the primary endpoint. 

Read more hubs.la/Q01R-Zmd0